The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose - PubMed (original) (raw)
The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose
R Lupi et al. Eur J Pharmacol. 1999.
Abstract
Pancreatic islet desensitization by high glucose concentrations is a temporary and reversible state of beta-cell refractoriness to glucose (and possibly other secretagogues), due to repeated or prolonged pre-exposure to increased glucose concentrations. We evaluated whether the oral antidiabetic agent metformin affects this phenomenon in isolated, human pancreatic islets, and whether the possible effects of the biguanide are influenced by the presence of a sulphonylurea, glyburide. Islets prepared from five human pancreases were incubated for 24 h in M199 culture medium containing either 5.5 or 22.2 mmol/l glucose, with or without a therapeutic concentration (2.4 microg/ml) of metformin. Then, the islets were challenged with either 3.3 mmol/l glucose, 16.7 mmol/l glucose, or 3.3 mmol/l glucose + 10 mmol/l arginine, and insulin release was measured. After incubation in the absence of metformin, the human islets exposed to 22.2 mmol/l glucose showed no significant increase in insulin release when challenged with 16.7 mmol/l glucose (confirming that hyperglycemia desensitizes pancreatic beta-cells). In the presence of metformin, the islets fully maintained the ability to significantly increase their insulin release in response to glucose, even when previously exposed to 22.2 mmol/l glucose. No major effect on arginine-induced insulin release was observed, whatever the culture conditions. The protective action of metformin was observed also when glyburide was present in the incubation medium, whereas the sulphonylurea alone did not affect insulin release from the islets previously exposed to high glucose concentrations. These in vitro results suggest that metformin can prevent the desensitization of human pancreatic islets induced by prolonged exposure to increased glucose concentrations.
Similar articles
- Lipotoxicity in human pancreatic islets and the protective effect of metformin.
Lupi R, Del Guerra S, Fierabracci V, Marselli L, Novelli M, Patanè G, Boggi U, Mosca F, Piro S, Del Prato S, Marchetti P. Lupi R, et al. Diabetes. 2002 Feb;51 Suppl 1:S134-7. doi: 10.2337/diabetes.51.2007.s134. Diabetes. 2002. PMID: 11815472 - Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.
Patanè G, Piro S, Rabuazzo AM, Anello M, Vigneri R, Purrello F. Patanè G, et al. Diabetes. 2000 May;49(5):735-40. doi: 10.2337/diabetes.49.5.735. Diabetes. 2000. PMID: 10905481 - Fast reversibility of glucose-induced desensitization in rat pancreatic islets. Evidence for an involvement of ionic fluxes.
Anello M, Rabuazzo AM, Degano C, Caltabiano V, Patanè G, Vigneri R, Purrello F. Anello M, et al. Diabetes. 1996 Apr;45(4):502-6. doi: 10.2337/diab.45.4.502. Diabetes. 1996. PMID: 8603773 - Effects of prolonged glucose stimulation on pancreatic beta cells: from increased sensitivity to desensitization.
Purrello F, Rabuazzo AM, Anello M, Patanè G. Purrello F, et al. Acta Diabetol. 1996 Dec;33(4):253-6. doi: 10.1007/BF00571559. Acta Diabetol. 1996. PMID: 9033963 Review. - [Action of metformin in insulin resistance].
Isnard F, Triadou N, Lavieuville M, Noël M. Isnard F, et al. Journ Annu Diabetol Hotel Dieu. 1985:307-17. Journ Annu Diabetol Hotel Dieu. 1985. PMID: 2577974 Review. French. No abstract available.
Cited by
- The development and benefits of metformin in various diseases.
Dong Y, Qi Y, Jiang H, Mi T, Zhang Y, Peng C, Li W, Zhang Y, Zhou Y, Zang Y, Li J. Dong Y, et al. Front Med. 2023 Jun;17(3):388-431. doi: 10.1007/s11684-023-0998-6. Epub 2023 Jul 4. Front Med. 2023. PMID: 37402952 Review. - Metabolic Adaptions/Reprogramming in Islet Beta-Cells in Response to Physiological Stimulators-What Are the Consequences.
Newsholme P, Rowlands J, Rose'Meyer R, Cruzat V. Newsholme P, et al. Antioxidants (Basel). 2022 Jan 4;11(1):108. doi: 10.3390/antiox11010108. Antioxidants (Basel). 2022. PMID: 35052612 Free PMC article. Review. - Metformin Preserves β-Cell Compensation in Insulin Secretion and Mass Expansion in Prediabetic Nile Rats.
Huang H, Lorenz BR, Zelmanovitz PH, Chan CB. Huang H, et al. Int J Mol Sci. 2021 Jan 3;22(1):421. doi: 10.3390/ijms22010421. Int J Mol Sci. 2021. PMID: 33401592 Free PMC article. - SGLT2-i improves markers of islet endothelial cell function in db/db diabetic mice.
Hogan MF, Hackney DJ, Aplin AC, Mundinger TO, Larmore MJ, Castillo JJ, Esser N, Zraika S, Hull RL. Hogan MF, et al. J Endocrinol. 2021 Feb;248(2):95-106. doi: 10.1530/JOE-20-0354. J Endocrinol. 2021. PMID: 33337344 Free PMC article. - DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway.
Dos Santos RS, Marroqui L, Velayos T, Olazagoitia-Garmendia A, Jauregi-Miguel A, Castellanos-Rubio A, Eizirik DL, Castaño L, Santin I. Dos Santos RS, et al. Diabetologia. 2019 Mar;62(3):459-472. doi: 10.1007/s00125-018-4782-0. Epub 2018 Nov 26. Diabetologia. 2019. PMID: 30478640
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical